Clinical Outcomes at 1 Year Following Transcatheter Left Atrial Appendage Occlusion in the United States. Academic Article uri icon

Overview

abstract

  • OBJECTIVES: The aim of this study was to report 1-year clinical outcomes following commercial transcatheter left atrial appendage occlusion (LAAO) in the United States. BACKGROUND: The National Cardiovascular Data Registry LAAO Registry was initiated to meet a condition of Medicare coverage and allow the assessment of clinical outcomes. The 1-year rates of thromboembolic events after transcatheter LAAO in such a large cohort of "real-world" patients have not been previously reported. METHODS: Patients entered into the National Cardiovascular Data Registry LAAO Registry for a Watchman procedure between January 1, 2016, and December 31, 2018, were included. The primary endpoint was ischemic stroke. Key secondary endpoints included the rate of ischemic stroke or systemic embolism, mortality, and major bleeding. Major bleeding was defined as any bleeding requiring hospitalization, and/or causing a decrease in hemoglobin level > 2g/dL, and/or requiring blood transfusion that was not hemorrhagic stroke. The Kaplan-Meier method was used for 1-year estimates of cumulative event rates. RESULTS: The study population consisted of 36,681 patients. The mean age was 76.0 ± 8.1 years, the mean CHA2DS2-VASc score was 4.8 ± 1.5, and the mean HAS-BLED score was 3.0 ± 1.1. Prior stroke was present in 25.5%, clinically relevant bleeding in 69.5%, and intracranial bleeding in 11.9%. Median follow-up was 374 days (IQR: 212-425 days). The Kaplan-Meier-estimated 1-year rate of ischemic stroke was 1.53% (95% CI: 1.39%-1.69%), the rate of ischemic stroke or systemic embolism was 2.19% (95% CI: 2.01%-2.38%), and the rate of mortality was 8.52% (95% CI: 8.19%-8.87%). The 1-year estimated rate of major bleeding was 6.93% (95% CI: 6.65%-7.21%). Most bleeding events occurred between discharge and 45 days following the procedure. CONCLUSIONS: This study characterizes important outcomes in a national cohort of patients undergoing transcatheter LAAO in the United States. Clinicians and patients can integrate these data in shared decision making when considering this therapy.

authors

  • Price, Matthew J
  • Slotwiner, David J
  • Du, Chengan
  • Freeman, James V
  • Turi, Zoltan
  • Rammohan, Chidambaram
  • Kusumoto, Fred M
  • Kavinsky, Clifford
  • Akar, Joseph
  • Varosy, Paul D
  • Koutras, Christina
  • Curtis, Jeptha P
  • Masoudi, Frederick A

publication date

  • April 11, 2022

Research

keywords

  • Atrial Appendage
  • Atrial Fibrillation
  • Ischemic Stroke
  • Stroke

Identity

PubMed Central ID

  • PMC9116488

Scopus Document Identifier

  • 85126952042

Digital Object Identifier (DOI)

  • 10.1016/j.jcin.2022.02.009

PubMed ID

  • 35393108

Additional Document Info

volume

  • 15

issue

  • 7